Union Therapeutics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.4M

  • Investors
  • 6

Union Therapeutics General Information

Description

Operator of an oral small-molecule pharmaceutical platform intended to develop and commercialize treatments for inflammatory and immunologic diseases. The company offers oral therapies targeting conditions such as psoriasis, atopic dermatitis, hidradenitis suppurativa, and rare immunologic diseases, enabling patients and healthcare providers to access treatments for diseases with significant unmet medical needs.

Contact Information

Formerly Known As
AntibioTx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tuborg Havnevej 18
  • 2900 Hellerup
  • Denmark
+45 61
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Tuborg Havnevej 18
  • 2900 Hellerup
  • Denmark
+45 61

Union Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Union Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 19-Jun-2026 $5.4M Completed Clinical Trials - Phase 2
12. Later Stage VC 13-Jul-2023 Completed Clinical Trials - Phase 2
11. Later Stage VC 16-Jul-2021 Completed Clinical Trials - Phase 2
10. Later Stage VC (Series A) 09-Feb-2021 Completed Clinical Trials - Phase 2
9. Later Stage VC 23-Jun-2020 Completed Clinical Trials - Phase 2
8. Grant 01-Mar-2020 Completed Clinical Trials - Phase 2
7. Later Stage VC 31-Dec-2017 Completed Clinical Trials - Phase 2
6. Accelerator/Incubator Completed Clinical Trials - Phase 1
5. Debt - General 26-Oct-2017 $23.6M $31M Completed Clinical Trials - Phase 1
4. Grant 01-Aug-2017 $4M $7.43M Completed Clinical Trials - Phase 1
To view Union Therapeutics’s complete valuation and funding history, request access »

Union Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares 7,922 $293.79 $293.79 1x $293.79 1.01%
Ordinary Shares 8,000 $659.44 $659.44 1x $659.44 1.02%
To view Union Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Union Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an oral small-molecule pharmaceutical platform intended to develop and commercialize treatments for inflamma
Drug Discovery
Hellerup, Denmark
6 As of 2026

Wilmington, DE
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Union Therapeutics Competitors (12)

One of Union Therapeutics’s 12 competitors is Incyte, a Formerly VC-backed company based in Wilmington, DE.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Incyte Formerly VC-backed Wilmington, DE
Apogee Therapeutics Formerly VC-backed Waltham, MA
LEO Pharma Private Equity-Backed Ballerup, Denmark
RAPT Therapeutics Formerly VC-backed South San Francisco, CA
Kymera Therapeutics Formerly VC-backed Watertown, MA
You’re viewing 5 of 12 competitors. Get the full list »

Union Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Union Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
T&W Medical Family Office Minority
European Investment Bank Investment Bank Minority
The Innovation Fund Venture Capital Minority
Horizon 2020 Government
Technical University of Denmark University
You’re viewing 5 of 6 investors. Get the full list »

Union Therapeutics Investments (1)

Union Therapeutics’s most recent deal was a Corporate Asset Purchase with LEO Pharma (Rights of PDE4 Inhibitor Series). The deal was made on 23-Jul-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
LEO Pharma (Rights of PDE4 Inhibitor Series) 23-Jul-2020 Corporate Asset Purchase Buildings and Property
To view Union Therapeutics’s complete investments history, request access »

Union Therapeutics FAQs

  • When was Union Therapeutics founded?

    Union Therapeutics was founded in 2011.

  • Where is Union Therapeutics headquartered?

    Union Therapeutics is headquartered in Hellerup, Denmark.

  • What is the size of Union Therapeutics?

    Union Therapeutics has 6 total employees.

  • What industry is Union Therapeutics in?

    Union Therapeutics’s primary industry is Drug Discovery.

  • Is Union Therapeutics a private or public company?

    Union Therapeutics is a Private company.

  • What is the current valuation of Union Therapeutics?

    The current valuation of Union Therapeutics is .

  • What is Union Therapeutics’s current revenue?

    The current revenue for Union Therapeutics is .

  • How much funding has Union Therapeutics raised over time?

    Union Therapeutics has raised $114M.

  • Who are Union Therapeutics’s investors?

    T&W Medical, European Investment Bank, The Innovation Fund, Horizon 2020, and Technical University of Denmark are 5 of 6 investors who have invested in Union Therapeutics.

  • Who are Union Therapeutics’s competitors?

    Incyte, Apogee Therapeutics, LEO Pharma, RAPT Therapeutics, and Kymera Therapeutics are some of the 12 competitors of Union Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process